WT1 126-134 Peptide Vaccine

A synthetic peptide vaccine consisting of the amino acids 126 through 134 of the human Wilms' Tumor protein-1 (WT1) with potential antitumor activity. WT1, a tumor associated antigen, is overexpressed in most types of leukemia and in a variety of solid cancers. Vaccination with WT1 126-134 peptide vaccine may induce a WT1-specific cytotoxic T-lymphocyte (CTL) response against WT1 expressing cells, resulting in cell lysis and inhibition of cancer cell proliferation. (NCI Thesaurus)

YOU MAY ALSO LIKE

WT1 124-138 Peptide Vaccine

A synthetic peptide vaccine consisting of a HLA-DR15-restricted human Wilms' Tumor protein-1 (WT1) peptide comprised of amino acids 124 through 138, a…

WS

An inherited disorder marked by rapid aging that begins in early adolescence. Patients may be shorter than average, and have health problems…

WRNIP1 wt Allele

Human WRNIP1 wild-type allele is located in the vicinity of 6p25.2 and is approximately 21 kb in length. This allele, which encodes…

WRNIP1 Gene

This gene is involved in both ATP hydrolysis and DNA replication.

WRN wt Allele

Human WRN wild-type allele is located within 8p12-p11.2 and is approximately 140 kb in length. This allele, which encodes Werner syndrome ATP-dependent…

WRN Gene

This gene is involved in DNA repair and the unwinding of DNA.